These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28718367)

  • 21. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
    Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
    Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raf1 is a prognostic factor for progression in patients with non‑small cell lung cancer after radiotherapy.
    Tian H; Yin L; Ding K; Xia YY; Wang XH; Wu JZ; He X
    Oncol Rep; 2018 Apr; 39(4):1966-1974. PubMed ID: 29484414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level.
    Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S
    Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
    Wang X; Feng Q; Yu H; Zhou X; Shan C; Zhang Q; Liu S
    Life Sci; 2020 Mar; 245():117354. PubMed ID: 31987874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of Sam68 expression in endometrial carcinoma.
    Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
    Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
    Xia H; Ma L; Li J; Bai H; Wang D
    Am J Cancer Res; 2017; 7(11):2190-2198. PubMed ID: 29218243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of high NQO1 expression in breast cancers.
    Yang Y; Zhang Y; Wu Q; Cui X; Lin Z; Liu S; Chen L
    J Exp Clin Cancer Res; 2014 Feb; 33(1):14. PubMed ID: 24499631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
    Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
    Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inversin correlates with the malignant phenotype of non-small cell lung cancer and promotes the invasiveness of lung cancer cells.
    Jiang GY; Zhang Y; Zhang XP; Lin XY; Yu JH; Wang EH
    Tumour Biol; 2017 Jun; 39(6):1010428317691177. PubMed ID: 28618971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
    Gharabaghi MA
    Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
    Chen X; Shao W; Huang H; Feng X; Yao S; Ke H
    Hum Pathol; 2019 Jan; 83():140-148. PubMed ID: 30172915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
    Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
    Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9.
    Wang R; Ke ZF; Wang F; Zhang WH; Wang YF; Li SH; Wang LT
    Cell Physiol Biochem; 2015; 35(3):969-82. PubMed ID: 25659977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
    Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
    Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
    Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
    BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.